VCYT
Veracyte, Inc.Recent alerts on VCYT
All signals →
Insider trade
Sale by EPSTEIN ROBERT S
10d ago
News
Diagnostic Company Veracyte Weighs Sale For French Subsidiary, Analyst Says 'Walking Away' Is A Long-Term Positive
14d ago
News
Insider Sale: Director Jens Holstein Sells 5,000 Shares of Veracyte Inc (VCYT) By GuruFocus - Investing.com Canada
14d ago
News
Globus Medical (GMED) Global Sales, Innovation Aid Growth - Zacks Investment Research
14d ago
News
Wall Street Analysts See a 37.09% Upside in Veracyte (VCYT): Can the Stock Really Move This High?
14d ago
News
Veracyte (VCYT) Crossed Above the 50-Day Moving Average: What That Means for Investors
14d ago
News
Wall Street Analysts Think Veracyte (VCYT) Could Surge 39.07%: Read This Before Placing a Bet
14d ago
News
Veracyte's (VCYT) New Findings to Advance Thyroid Cancer Care
14d ago
News
Cathie Wood’s weekly update: buys Cerebras, Tempus AI, sells AMD and TSM
15d ago
News
Cathie Wood's weekly recap: buys TEM, WGS, and CRWV; sells AMD and RKLB
22d ago
Insider trade
Sale by Annie Mcguire (SVP, General Counsel)
24d ago
Scanner
Large up move: 24.9% (2.1x normal daily movement)
25d ago
Scanner
Large up move: 24.9% (2.2x normal daily movement)
26d ago
News
Cathie Wood's ARK boosts Palantir, Tesla, Roninhood bets; cuts semiconductor exposure
27d ago
News
Veracyte GAAP EPS of $0.35 beats by $0.21, revenue of $139.1M beats by $8.71M
27d ago
Insider trade
Sale by Rebecca Chambers (Chief Financial Officer)
87d ago
Insider trade
Sale by Marc Stapley (Chief Executive Officer)
87d ago
Insider trade
Sale by John Leite (Chief Commercial Officer-CLIA)
87d ago
Insider trade
Sale by Annie Mcguire (SVP, General Counsel)
87d ago
Insider trade
Sale by Phillip G. Febbo (Chief Scientific & Med Officer)
89d ago
News
Cathie Wood's Ark Invest buys the dip in tech and crypto, bags AMD, GOOG, CRCL, and HOOD
113d ago
News
Veracyte reports Q4 preliminary revenue in the range of $138M - $140M
141d ago
News
Verallia appoints Cristina Riesgo as CFO
147d ago
News
NATHALIE DELBREUVE EST NOMMÉE DIRECTRICE FINANCIERE DE VALLOUREC ET REJOINT LE COMITE EXECUTIF DU GROUPE
155d ago
News
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)
155d ago
Get push alerts for VCYT
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS